A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06153251 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: BMS-986453
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company